FDA Grants Priority Review to Afami-Cel BLA in Advanced Synovial Sarcoma
The FDA has accepted for priority review the BLA seeking the approval of afamitresgene autoleucel for the treatment of advanced synovial sarcoma.
United States Dennis Williams Adrian Rawcliffe Connective Tissue Oncology Society Stage Development Prescription Drug User Fee Act
Source: onclive.com